Rain Oncology is a publicly traded company trading on XNAS, led by CEO Randall Seidl, with a market cap of $19.2M.
Common questions about Rain Oncology
Rain Oncology is scheduled to report earnings for Q1 2026 on May 20, 2026.
Rain Oncology has approximately 63 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.